Alabama Attorney General Steve Marshall has shut down a Cullman IV clinic after allegations it gave patients unsafe, research ...

This collaboration combines Novo Nordisk’s innovation in GLP-1 therapies with Emcure’s marketing and distribution strengths ...

Novo Nordisk has partnered with Emcure Pharma to distribute and market its diabetes and weight loss injection semaglutide under the brand name Poviztra in India. This collaboration aims to expand ...

Danish drugmaker Novo Nordisk announced a partnership with Emcure Pharma on Monday to launch its Poviztra, semaglutide injection 2.4 mg, in India. Poviztra is the second brand of its weight loss drug ...

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.

Thirteen drugs for cancer and diabetes have been added to the list of essential medicines exempted from value-added tax or VAT, according to the Food and Drug Administration (FDA). Cancer drugs ...

Secondary analyses of the ESSENCE trial were presented at the American Association for the Study of Liver Diseases (AASLD), ...

Poviztra to be sold as 2.4 mg injectable; Emcure becomes first Indian firm with exclusive semaglutide distribution rights ...

Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...

Heathrow Airport security staff intercepted criminals smuggling potentially counterfeit Mounjaro pens hidden on their bodies.

Semaglutide, also injected weekly ... Liraglutide, given as a daily injection, produced a modest average weight loss of approximately 4–5%, as shown in 24 trials with 9,937 participants. Even so, it ...

Novo Nordisk India has joined forces with Emcure Pharmaceuticals to commercialize Poviztra, a weight-loss drug, in an effort ...